CNST News and Press, Constellation Pharmaceuticals Inc. From 02/26/20

CAMBRIDGE, Mass., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar Raythatha, CEO, will present ...

What stock will go up the most in 2020? We'd all like to know that one. And it's a question that's a lot easier to ask than to answer. Let's start by looking at the  top 10 stocks of 2019  for clues. The No. 1 stock of 2019,  Axsome Therapeutics , had a staggering 3,578% retu...

Abbott (NYSE: ABT ) resumed with Neutral rating and $96 (8% upside) price target at Goldman Sachs. Shares down  1%  premarket. More news on: Abbott Laboratories, Baxter International Inc., Boston Scientific Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

Today, we will see why Constellation Pharmaceuticals ( CNST ) is an attractive pick for 2020. Company overview Constellation Pharmaceuticals is a clinical-stage biopharmaceutical company focused on deploying epigenetics for the development of therapies targeting cancers associated with a...

Arcturus Therapeutics (NASDAQ: ARCT ) initiated with Buy rating and $19 (70% upside) price target at Guggenheim. More news on: Arcturus Therapeutics Holdings Inc., BeyondSpring Inc., Millendo Therapeutics, Inc., Healthcare stocks news, Stocks on the move, , Read more ...

Quick Take Revolution Medicines ( RVMD ) intends to raise $150 million from the sale of its common stock, according to an amended registration statement. The company is in Phase 1/2 trials for the development of treatments for various types of cancers. RVMD has produced promising early r...

CAMBRIDGE, Mass., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Constellation Pharmaceuticals , Inc. (Nasdaq: CNST), a clinical-stage biopharmaceutical company using its expertise in epigenetics to discover and develop novel therapeutics, today announced that Jigar Raythatha, CEO, will present ...

The top 10 stocks of 2019 are an interesting group. You might think tech stocks would dominate the upper echelon of equities, but you'd be wrong. As we saw in the IPO market , individual healthcare stocks actually had the strongest returns last year. Seven biotech companies made our list, inc...

Like Making Money With Penny Stocks? These Won Big This Year Investing in penny stocks has often proven to be the best way in which people can generate enormous returns within a short period of time. So, the interest in these stocks has always been high. Every year, certain penny stocks prov...

2019 will go down in history as one of the best years ever for the stock market. Biotech stocks , in general, have performed very well. And some biotech stocks have delivered staggering gains. Axsome Therapeutics (NASDAQ: AXSM) , Constellation Pharmaceuticals (NASDAQ: CNST) , and Kodiak...